Harrow, Inc. Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down
Harrow, Inc. (HROW) reported Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down of $111.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown · last filed 2017-08-10
- 2017-06-30: Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 6 month $111.00K.
| Period end | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 6 month |
|---|---|
| 2017-06-30 | $111.00K 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |